Country Trust Bank boosted its position in shares of CVS Health Corp (NYSE:CVS) by 1.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 302,508 shares of the pharmacy operator’s stock after buying an additional 4,024 shares during the period. Country Trust Bank’s holdings in CVS Health Corp were worth $23,747,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of CVS. SRS Capital Advisors Inc. purchased a new stake in CVS Health Corp during the fourth quarter valued at $120,000. D Orazio & Associates Inc. increased its stake in shares of CVS Health Corp by 34.5% in the fourth quarter. D Orazio & Associates Inc. now owns 1,560 shares of the pharmacy operator’s stock worth $123,000 after buying an additional 400 shares during the last quarter. Elgethun Capital Management bought a new stake in shares of CVS Health Corp during the fourth quarter worth approximately $133,000. Sowell Financial Services LLC bought a new stake in shares of CVS Health Corp during the fourth quarter worth approximately $140,000. Finally, Patriot Financial Group Insurance Agency LLC bought a new stake in shares of CVS Health Corp during the fourth quarter worth approximately $156,000. 81.29% of the stock is owned by institutional investors and hedge funds.
CVS Health Corp (NYSE:CVS) traded down 0.43% on Thursday, reaching $76.09. The company had a trading volume of 3,658,198 shares. The stock’s 50-day moving average price is $79.24 and its 200 day moving average price is $79.00. CVS Health Corp has a 52-week low of $69.30 and a 52-week high of $98.67. The firm has a market capitalization of $77.52 billion, a price-to-earnings ratio of 15.87 and a beta of 0.85.
CVS Health Corp (NYSE:CVS) last posted its quarterly earnings data on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.07. The company had revenue of $44.51 billion during the quarter, compared to analysts’ expectations of $44.20 billion. CVS Health Corp had a net margin of 3.00% and a return on equity of 17.55%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 EPS. On average, equities analysts anticipate that CVS Health Corp will post $5.87 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, May 1st. Shareholders of record on Friday, April 21st were given a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.62%. CVS Health Corp’s payout ratio is currently 40.65%.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by sleekmoney and is owned by of sleekmoney. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://sleekmoney.com/country-trust-bank-has-23-747-million-stake-in-cvs-health-corp-cvs/1853319.html.
A number of equities analysts recently weighed in on the company. Guggenheim reaffirmed a “buy” rating and issued a $90.00 price target on shares of CVS Health Corp in a report on Monday, February 6th. Bank of America Corp reaffirmed a “buy” rating and issued a $106.67 price target on shares of CVS Health Corp in a report on Tuesday, February 28th. Leerink Swann set a $90.00 price target on CVS Health Corp and gave the stock a “buy” rating in a report on Saturday, February 11th. Evercore ISI reduced their price target on CVS Health Corp from $91.50 to $84.00 and set a “buy” rating for the company in a report on Thursday, February 9th. Finally, Vetr raised CVS Health Corp from a “hold” rating to a “buy” rating and set a $85.70 price target for the company in a report on Monday, April 3rd. Seven analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $94.39.
In other news, EVP Andrew Sussman sold 14,104 shares of the company’s stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $80.40, for a total value of $1,133,961.60. Following the sale, the executive vice president now owns 22,801 shares in the company, valued at approximately $1,833,200.40. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Eva C. Boratto sold 6,029 shares of the company’s stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $79.60, for a total transaction of $479,908.40. Following the completion of the sale, the executive vice president now owns 41,614 shares in the company, valued at approximately $3,312,474.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 139,600 shares of company stock valued at $11,205,962. 0.58% of the stock is currently owned by corporate insiders.
About CVS Health Corp
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/country-trust-bank-has-23-747-million-stake-in-cvs-health-corp-cvs/1853319.html
Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.